CINCINNATI, Feb. 13 /PRNewswire/ -- Blaine Pharmaceuticals is pleased to announce the addition of David Paragamian to its Business Advisory Board. Mr. Paragamian brings a wealth of business experience and a strong knowledge of the pharmaceutical/healthcare industry. He will provide valued counsel as Blaine focuses its marketing efforts on introducing new products to increase the quality of life for consumers impacted by the growing epidemic of diabetes.
David is currently the Chief Operating Officer of GSW Worldwide Advertising, a division of inChord Communications in Columbus, Ohio. As a senior agency executive, he has demonstrated leadership skills, a proven track record as a general manager and a strong knowledge of the pharmaceutical/healthcare industry. David has delivered outstanding results both on the client side for more than 15 years, as well as general manager for almost 6 years in agency cultures. David has established himself in such companies as Rhone Poulenc Rorer Pharmaceuticals (now Sanofi-Aventis), Roche Diagnostics, Information Resources, Inc., and Publicis Healthcare/Saatchi & Saatchi Advertising.
Blaine Pharmaceuticals has already gained over-the-counter distribution for its flagship product, Mag-Ox 400(R) in over 28,000 locations, including Walgreens, CVS/pharmacy, Rite Aid, Kroger, Brooks/Eckerd, Albertson’s and other fine retailers. This move represents one of the first steps in a bold, new sales and marketing strategy for the company -- which had traditionally marketed its products directly to physicians and pharmacists -- and for the product, which had previously been sold behind the counter (even though no prescription was required). David’s advisory role will be key in launching several new products in 2006.
About Blaine Pharmaceuticals
Blaine has a fifty-year history of providing health care solutions and today is a driving force behind the magnesium market, setting the standard with quality products such as the #1 doctor recommended, Mag-Ox 400(R). In 2006, Blaine will be introducing new, innovative products for diabetes health. For more information visit www.blainepharma.com and www.MagOx.com.
Blaine Pharmaceuticals
CONTACT: Gina Wendling of Blaine Pharmaceuticals, +1-859-344-9600 x18, orgwendling@blainepharma.com
